Ankit Kumar Singh

1.2k total citations · 1 hit paper
47 papers, 750 citations indexed

About

Ankit Kumar Singh is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Ankit Kumar Singh has authored 47 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Organic Chemistry and 14 papers in Computational Theory and Mathematics. Recurrent topics in Ankit Kumar Singh's work include Synthesis and biological activity (18 papers), Computational Drug Discovery Methods (14 papers) and Melanoma and MAPK Pathways (8 papers). Ankit Kumar Singh is often cited by papers focused on Synthesis and biological activity (18 papers), Computational Drug Discovery Methods (14 papers) and Melanoma and MAPK Pathways (8 papers). Ankit Kumar Singh collaborates with scholars based in India, Russia and Saudi Arabia. Ankit Kumar Singh's co-authors include Pradeep Kumar, Adarsh Kumar, Harshwardhan Singh, Amita Verma, Prateek Pathak, Maria Grishina, Jagat Pal Yadav, Suresh Thareja, Mariusz Jaremko and Abdul‐Hamid Emwas and has published in prestigious journals such as Advanced Materials, Scientific Reports and Chemosphere.

In The Last Decade

Ankit Kumar Singh

43 papers receiving 737 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective

2023 181 citations Adarsh Kumar, Ankit Kumar Singh et al. Pharmaceuticals profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ankit Kumar Singh India	13	361	264	148	78	38	47	750
Shuo Yuan China	18	383 1.1×	415 1.6×	133 0.9×	29 0.4×	30 0.8×	73	933
Hala B. El‐Nassan Egypt	17	531 1.5×	274 1.0×	88 0.6×	63 0.8×	20 0.5×	50	831
Alaa M. Alqahtani Saudi Arabia	14	279 0.8×	191 0.7×	59 0.4×	51 0.7×	38 1.0×	54	719
Katarzyna Kotwica-Mojzych Poland	16	416 1.2×	188 0.7×	92 0.6×	43 0.6×	10 0.3×	37	749
Qidong Tang China	19	415 1.1×	380 1.4×	96 0.6×	56 0.7×	67 1.8×	51	817
Tamer Nasr Egypt	16	684 1.9×	345 1.3×	113 0.8×	62 0.8×	20 0.5×	48	1.0k
Adarsh Kumar India	14	378 1.0×	315 1.2×	151 1.0×	83 1.1×	50 1.3×	54	841
Wael A. El‐Sayed Egypt	27	1.7k 4.8×	522 2.0×	163 1.1×	123 1.6×	38 1.0×	125	2.1k
Awwad A. Radwan Saudi Arabia	15	313 0.9×	212 0.8×	64 0.4×	43 0.6×	21 0.6×	55	770
Gugan Kothandan India	14	117 0.3×	292 1.1×	114 0.8×	148 1.9×	11 0.3×	53	598

Countries citing papers authored by Ankit Kumar Singh

Since Specialization

Citations

This map shows the geographic impact of Ankit Kumar Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankit Kumar Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankit Kumar Singh more than expected).

Fields of papers citing papers by Ankit Kumar Singh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ankit Kumar Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankit Kumar Singh. The network helps show where Ankit Kumar Singh may publish in the future.

Co-authorship network of co-authors of Ankit Kumar Singh

This figure shows the co-authorship network connecting the top 25 collaborators of Ankit Kumar Singh. A scholar is included among the top collaborators of Ankit Kumar Singh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ankit Kumar Singh. Ankit Kumar Singh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Singh, Ankit Kumar, Adarsh Kumar, Katarina Kraljic, et al.. (2025). Thioxo-tetrahydro-pyrimidin-benzenesulfonamide hybrids as potential BRAFV600E inhibitors: experimental, computational and biological evaluations. Journal of Molecular Structure. 1349. 143620–143620. 1 indexed citations

Kumar, Adarsh, Ankit Kumar Singh, Harshwardhan Singh, et al.. (2025). Synthesis and anticancer evaluation of novel pyrrole-pyrido[2,3-d] pyrimidine-based compounds as thymidylate synthase inhibitors. Journal of Molecular Structure. 1336. 142053–142053. 2 indexed citations

Prajapati, Vimal H., Ankit Kumar Singh, Adarsh Kumar, et al.. (2025). Structural insights, regulation, and recent advances of RAS inhibitors in the MAPK signaling cascade: a medicinal chemistry perspective. RSC Medicinal Chemistry. 16(5). 1923–1940. 2 indexed citations

Kumar, Adarsh, Ankit Kumar Singh, Vimal H. Prajapati, et al.. (2025). Medicinal Chemistry Perspective of 1,8‐Naphthyridines as Anticancer Agents. Chemistry & Biodiversity. 22(12). e01396–e01396.

Kumar, Vineet, K.P.S. Rana, & Ankit Kumar Singh. (2024). An efficient fractional-order self-adjusted fuzzy PD regulator for nonlinear mechanical systems. Chaos Solitons & Fractals. 188. 115474–115474. 2 indexed citations

Kumar, Adarsh, et al.. (2024). Ethnomedicinal Uses, Phytochemistry, Pharmacology, and Toxicology of Ruellia tuberosa L.: A Review. Chemistry & Biodiversity. 21(8). e202400292–e202400292. 1 indexed citations

Kumar, Adarsh, Ankit Kumar Singh, Harshwardhan Singh, Balasubramanian Narasimhan, & Pradeep Kumar. (2024). Synthesis and Anticancer Evaluation of Benzylated Indole Based Alkyl‐Substituted Pyrido[2,3‐ d ]Pyrimidines Targeting Thymidylate Synthase. ChemistrySelect. 9(15).

Singh, Ankit Kumar, Prateek Pathak, Adarsh Kumar, et al.. (2024). Design, Virtual Screening, Molecular Docking, ADME and Cytotoxicity Studies of 1,3,5-Triazine Containing Heterocyclic Scaffolds as Selective BRAF Monomeric, Homo and Heterodimeric Inhibitors. Combinatorial Chemistry & High Throughput Screening. 28(13). 2351–2368. 1 indexed citations

Yadav, Jagat Pal, Ankit Kumar Singh, Maria Grishina, et al.. (2024). Insights into the mechanisms of diabetic wounds: pathophysiology, molecular targets, and treatment strategies through conventional and alternative therapies. Inflammopharmacology. 32(1). 149–228. 41 indexed citations

10.

Singh, Vipendra Kumar, et al.. (2024). Role of MicroRNA-21 in Prostate Cancer Progression and Metastasis: Molecular Mechanisms to Therapeutic Targets. Annals of Surgical Oncology. 31(7). 4795–4808. 6 indexed citations

11.

Kumar, Adarsh, et al.. (2023). In Silico Studies of Indole Derivatives as Antibacterial Agents. Journal of pharmacopuncture. 26(2). 147–157. 6 indexed citations

12.

Kumar, Adarsh, Jurica Novak, Ankit Kumar Singh, et al.. (2023). Virtual screening, structure based pharmacophore mapping, and molecular simulation studies of pyrido[2,3-d]pyrimidines as selective thymidylate synthase inhibitors. Journal of Biomolecular Structure and Dynamics. 41(23). 14197–14211. 7 indexed citations

13.

Singh, Ankit Kumar, Adarsh Kumar, Harshwardhan Singh, et al.. (2023). Description and In silico ADME Studies of US-FDA Approved Drugs orDrugs under Clinical Trial which Violate the Lipinski’s Rule of 5. Letters in Drug Design & Discovery. 21(8). 1334–1358. 14 indexed citations

14.

Kumar, Adarsh, Ankit Kumar Singh, Harshwardhan Singh, et al.. (2023). Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective. Pharmaceuticals. 16(2). 299–299. 181 indexed citations breakdown →

15.

Kumar, Rohit, et al.. (2023). Design, Synthesis and Molecular Docking Studies of Pyrazoline Derivativesas PI3K Inhibitors. Combinatorial Chemistry & High Throughput Screening. 27(2). 256–272. 2 indexed citations

16.

Singh, Harshwardhan, et al.. (2023). Medicinal Chemistry Aspects of Isoxazole Analogues as Anti-tubercular Agents. Current Organic Chemistry. 27(15). 1308–1318. 1 indexed citations

17.

Kumar, Adarsh, et al.. (2023). Medicinal chemistry aspects of uracil containing dUTPase inhibitors targeting colorectal cancer. Drug Discovery Today. 29(1). 103853–103853. 4 indexed citations

18.

Singh, Ankit Kumar, Adarsh Kumar, Sahil Arora, et al.. (2023). Current insights and molecular docking studies of HIV‐1 reverse transcriptase inhibitors. Chemical Biology & Drug Design. 103(1). e14372–e14372. 11 indexed citations

19.

Singh, Ankit Kumar, Jawed Iqbal, Jasmina Sulejmanović, et al.. (2022). Advancements of sequencing batch biofilm reactor for slaughterhouse wastewater assisted with response surface methodology. Chemosphere. 307(Pt 3). 135952–135952. 26 indexed citations

20.

Kumar, Adarsh, Ankit Kumar Singh, Harshwardhan Singh, Suresh Thareja, & Pradeep Kumar. (2022). Regulation of thymidylate synthase: an approach to overcome 5-FU resistance in colorectal cancer. Medical Oncology. 40(1). 3–3. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact